|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/443 | |
| A61P 35/02 | |||
| C07D 405/12 |
| (11) | Number of the document | 3329917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16830602.5 |
| Date of filing the European patent application | 2016-07-29 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/072262 |
| Date | 2016-07-29 |
| (87) | Number | WO 2017/018499 |
| Date | 2017-02-02 |
| (30) | Number | Date | Country code |
| 2015151170 | 2015-07-30 | JP |
| (72) |
WATANABE, Toshiki, JP
YAMAGISHI, Makoto, JP
KANNO, Osamu, JP
WATANABE, Jun, JP
ADACHI, Nobuaki, JP
HONMA, Daisuke, JP
HAMADA, Yoshito, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426,
JP
The University Of Tokyo, 3-1 Hongo 7-chome Bunkyo-ku, Tokyo 113-8654, JP |
| (54) | THERAPEUTIC AND/OR PROPHYLACTIC AGENT FOR ADULT T CELL LEUKEMIA/LYMPHOMA |
| THERAPEUTIC AND/OR PROPHYLACTIC AGENT FOR ADULT T CELL LEUKEMIA/LYMPHOMA |